Korean name: 씨제이 홍경천 등 복합추출물. This page reports what South Korea's
Ministry of Food and Drug Safety has approved for this ingredient.
MFDS recognition no.
2005-23
Approval route
Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)
‘씨제이홍경천등복합추출물’로서
Approval holder
씨제이(주)
Approved functional claim (Korean original)
The text below is the approved wording as published by MFDS. It is reproduced without
modification. Any translation is provided for comprehension only and carries no regulatory
standing.
"씨제이홍경천등복합추출물은 혈당조절을 신경 쓰시는 분들의 공복혈당 조절에 도움을 줄 수 있으나 아직은 과학적 근거가 부족합니다."
◆ 소수의 인체시험에서 여러 혈당조절 지표 중 공복혈당만이 유의적으로 감소되었으나 이를 설명할 수 있는 과학적 근거가 부족합니다. 따라서 반드시 ‘---에 도움을 줄 수 있으나 아직은 과학적 근거가 부족합니다’의 형식으로 표시하여야 함.
Precautions (Korean original)
◆ 유?소아, 임산부, 수유부는 사용을 삼가는 것이 좋습니다.
◆ 혈당조절을 위한 의약품을 복용하시는 분은 의사와 상담하시기 바랍니다.
What this means for sourcing
An ingredient approved in Korea is not automatically permitted elsewhere. Importers should
verify status with their own authority. Conversely, Korean approval demonstrates that a dossier
on safety and function was reviewed under a national regulatory system, which many buyers treat
as a meaningful signal.
Regulatory approvals described on this page were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts; it does not recommend or endorse any product.